# Halia Therapeutics

**Canonical:** https://apis.io/providers/halia-therapeutics/  
**Website:** https://haliatx.com/  
**APIs profiled:** 0

Halia Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company headquartered in Lehi, Utah, founded in 2017 and led by CEO Dr. David Bearss. Halia discovers and develops small-molecule therapies that target the immune system's inflammatory response — chiefly allosteric NEK7/NLRP3 inflammasome inhibition and LRRK2 inhibition — to resolve the chronic inflammation that drives hematologic, metabolic and neurodegenerative disease. Its lead clinical program, ofirnoflast (HT-6184), holds FDA Fast Track and Orphan Drug designation for lower-risk myelodysplastic syndromes; HT-4253, an LRRK2 inhibitor aimed at neuroinflammation and Alzheimer's prevention in APOE4 carriers, has completed a first-in-human Phase 1 study. The company also markets a "genetic resilience" research platform (GENMOR) built on family-cohort genomics. Halia is a drug developer, not a software vendor: it publishes a Webflow corporate site with pipeline, platform and press pages, and no developer program, public API, SDK or machine-readable specification of any kind.

## Kin Score — 7.6 / 100 (minimal)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (+0.0 from 7.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Halia Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Drug Discovery, Clinical Trials, Immunology, Neuroscience, Genomics, Health

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/halia-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.